118 related articles for article (PubMed ID: 21228360)
1. Phenotypic and genotypic characterization of carcinomas of the papilla of Vater has prognostic and putative therapeutic implications.
Kohler I; Jacob D; Budzies J; Lehmann A; Weichert W; Schulz S; Neuhaus P; Röcken C
Am J Clin Pathol; 2011 Feb; 135(2):202-11. PubMed ID: 21228360
[TBL] [Abstract][Full Text] [Related]
2. Low incidence of KRAS, BRAF, and PIK3CA mutations in adenocarcinomas of the ampulla of Vater and their prognostic value.
Kwon MJ; Kim JW; Jung JP; Cho JW; Nam ES; Cho SJ; Kim JS; Park HR; Min SK; Seo J; Min KW; Kim DH; Jeon JY
Hum Pathol; 2016 Apr; 50():90-100. PubMed ID: 26997442
[TBL] [Abstract][Full Text] [Related]
3. Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas.
Perysinakis I; Minaidou E; Leontara V; Mantas D; Sotiropoulos GC; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Int J Surg Pathol; 2017 Feb; 25(1):31-40. PubMed ID: 27543509
[TBL] [Abstract][Full Text] [Related]
4. Survival in ampullary cancer: potential role of different KRAS mutations.
Valsangkar NP; Ingkakul T; Correa-Gallego C; Mino-Kenudson M; Masia R; Lillemoe KD; Fernández-del Castillo C; Warshaw AL; Liss AS; Thayer SP
Surgery; 2015 Feb; 157(2):260-8. PubMed ID: 25616942
[TBL] [Abstract][Full Text] [Related]
5. Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
Hansel DE; Maitra A; Lin JW; Goggins M; Argani P; Yeo CJ; Piantadosi S; Leach SD; Biankin AV
J Clin Oncol; 2005 Mar; 23(9):1811-8. PubMed ID: 15774774
[TBL] [Abstract][Full Text] [Related]
6. Histopathologic features and microsatellite instability of cancers of the papilla of vater and their precursor lesions.
Ruemmele P; Dietmaier W; Terracciano L; Tornillo L; Bataille F; Kaiser A; Wuensch PH; Heinmoeller E; Homayounfar K; Luettges J; Kloeppel G; Sessa F; Edmonston TB; Schneider-Stock R; Klinkhammer-Schalke M; Pauer A; Schick S; Hofstaedter F; Baumhoer D; Hartmann A
Am J Surg Pathol; 2009 May; 33(5):691-704. PubMed ID: 19252434
[TBL] [Abstract][Full Text] [Related]
7. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
8. Intestinal and pancreatobiliary differentiation in periampullary carcinoma: the role of immunohistochemistry.
Kumari N; Prabha K; Singh RK; Baitha DK; Krishnani N
Hum Pathol; 2013 Oct; 44(10):2213-9. PubMed ID: 23834763
[TBL] [Abstract][Full Text] [Related]
9. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
[TBL] [Abstract][Full Text] [Related]
10. Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater.
Chang DK; Jamieson NB; Johns AL; Scarlett CJ; Pajic M; Chou A; Pinese M; Humphris JL; Jones MD; Toon C; Nagrial AM; Chantrill LA; Chin VT; Pinho AV; Rooman I; Cowley MJ; Wu J; Mead RS; Colvin EK; Samra JS; Corbo V; Bassi C; Falconi M; Lawlor RT; Crippa S; Sperandio N; Bersani S; Dickson EJ; Mohamed MA; Oien KA; Foulis AK; Musgrove EA; Sutherland RL; Kench JG; Carter CR; Gill AJ; Scarpa A; McKay CJ; Biankin AV
J Clin Oncol; 2013 Apr; 31(10):1348-56. PubMed ID: 23439753
[TBL] [Abstract][Full Text] [Related]
11. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater.
Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M
Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539
[TBL] [Abstract][Full Text] [Related]
12. Adenocarcinoma of the ampulla of Vater: does the histopathologic type matter?
Amptoulach S; Josefsson A; Kavantzas N; Kalaitzakis E
Scand J Gastroenterol; 2011 Nov; 46(11):1401-3. PubMed ID: 21854095
[No Abstract] [Full Text] [Related]
13. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms.
Kermanshahi TR; Jayachandran P; Chang DT; Pai R
Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300
[TBL] [Abstract][Full Text] [Related]
14. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
15. Signet ring cell carcinoma of the ampulla of Vater: demonstration of a pancreatobiliary origin.
Gheza F; Cervi E; Pulcini G; Villanacci V; Giulini SM; Schiavo-Lena M; Ferrari AB; Bassotti G
Pancreas; 2011 Jul; 40(5):791-3. PubMed ID: 21673543
[No Abstract] [Full Text] [Related]
16. Pathogenesis of carcinoma of the papilla of Vater.
Fischer HP; Zhou H
J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for ampullary adenocarcinomas: tumor stage, tumor histology, tumor location, immunohistochemistry and microsatellite instability.
Sessa F; Furlan D; Zampatti C; Carnevali I; Franzi F; Capella C
Virchows Arch; 2007 Sep; 451(3):649-57. PubMed ID: 17653761
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the location and the histomorphological/immunohistochemical characteristics of noninvasive neoplasms of the ampulla of Vater.
Yamamoto Y; Nemoto T; Okubo Y; Nihonyanagi Y; Ishiwatari T; Takuma K; Tochigi N; Okano N; Wakayama M; Igarashi Y; Shibuya K
Hum Pathol; 2014 Sep; 45(9):1910-7. PubMed ID: 25081540
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of immunohistochemical expression of CK7 and CK20 in curatively resected ampulla of Vater cancer.
Yun SP; Seo HI
BMC Gastroenterol; 2015 Nov; 15():165. PubMed ID: 26603157
[TBL] [Abstract][Full Text] [Related]
20. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
